Milliseconds Matter: How Wärtsilä’s Battery Tech Is Reinventing Grid Reliability
From ship engines to smart batteries, 190-year-old Wärtsilä has reinvented itself as an energy storage powerhouse with lightning-fast speeds.
Quenching Global Demand: How Nerovate Is Using AI and Lean Principles to Revolutionize Water Management
With over 25 years in digital transformation, Victor AbouRahal is setting his sights on wringing out wasted water costs.
What if you could simply pull carbon out of the atmosphere?
Charles Cadieu explains Spiritus' innovative CO2 capture solution: carbon orchards.
Hydro-Québec's energy storage spin-out EVLO might be key to a more reliable grid
“The energy transition isn’t just my job—it’s what drives me,” How Sonia St-Arnaud is tackling one of the biggest challenges in clean power.
CAR T-cell therapies are expensive and unsustainable - Cytiva are trying to change that
Emmanuel Abate reveals how Cytiva are making cell therapy manufacturing faster, greener, and fit for the future.
Could compressed air be the key to sustainable energy storage?
Hydrostor’s CEO explains how revolutionizing an old technology is helping to create a cheaper and more sustainable energy grid.
How Puro.earth became the first public registry dedicated to carbon removal
Antti Vihavainen reveals the science, standards, and momentum behind the global carbon removal market.
The future of fluorescence is smaller, smarter, and more accessible
FLIM LABS is redesigning the tools of fluorescence-lifetime imaging to enable broader access across medicine, pharma, and environmental science.
"It's like Duolingo for sewing" - how Della Yellow is ushering in the age of circular fashion
A digital community for clothing repairs has high hopes to upskill consumers worldwide and trigger an upcycle revolution.
How Piramal Pharma plans to become a multi-billion dollar business
Peter DeYoung lends insights on the strategic approach behind Piramal Phama’s expansion and growth.
We all want our hospital records in one place. Is Novellia the app to do it?
Shashi Shankar explains how his app unifies patients' scattered medical records all together, and what that has to do with the 21st Century Cures Act.
Backed by AstraZeneca, this company is helping radioligand cancer therapies hit the shelves
"Think of us as a critical partner in the ecosystem, ensuring that brilliant innovation doesn’t get stuck in the development phase but actually reaches the patients who need them."
CAR-T can only treat 3% of cancer patients. Mongoose Bio is building for the other 97%
Neil Warma explains how Mongoose Bio is pioneering TCR-T therapies that may last longer, tackle more cancers, and require less from patients.
This biotech is targeting the 'immortality switch' to fight blood cancers
Harnessing Nobel Prize-winning insights on telomeres, Geron’s CEO Dr. John A. Scarlett is taking on some of hematology’s toughest challenges—and winning FDA backing in the process.
NVIDIA’s Biggest Bet Yet: How Recursion Is Powering a New Era of AI-Driven Drug Discovery
“Almost all of the data that we use comes from our own laboratories - data generation doing real experiments in human biology… The AI side of things will be commoditized eventually, and the winners will be those who have the strongest data moat in life sciences.”
From Grammys to Gene Therapy: Gaurav Shah’s Rocket-Fueled Revolution in Rare Diseases
A Grammy-winning CEO is taking gene therapy to new heights.